Equities Analysts Issue Forecasts for CME Group Inc.’s Q3 2024 Earnings (NASDAQ:CME)

CME Group Inc. (NASDAQ:CME) – Equities researchers at Zacks Research raised their Q3 2024 EPS estimates for shares of CME Group in a research note issued to investors on Tuesday, August 13th. Zacks Research analyst T. De now forecasts that the financial services provider will earn $2.40 per share for the quarter, up from their prior forecast of $2.35. The consensus estimate for CME Group’s current full-year earnings is $9.80 per share. Zacks Research also issued estimates for CME Group’s FY2024 earnings at $9.77 EPS, Q1 2025 earnings at $2.52 EPS, Q2 2025 earnings at $2.46 EPS, Q3 2025 earnings at $2.45 EPS, FY2025 earnings at $9.63 EPS, Q1 2026 earnings at $2.67 EPS, Q2 2026 earnings at $2.60 EPS and FY2026 earnings at $10.25 EPS.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The company had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. CME Group’s quarterly revenue was up 12.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.30 earnings per share.

Other equities analysts also recently issued research reports about the stock. Barclays boosted their price target on shares of CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft upped their target price on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday. Piper Sandler cut their price target on CME Group from $235.00 to $225.00 and set an “overweight” rating on the stock in a report on Thursday, July 25th. Bank of America increased their price objective on CME Group from $209.00 to $216.00 and gave the stock a “neutral” rating in a report on Thursday, April 25th. Finally, JPMorgan Chase & Co. lifted their target price on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $213.27.

CME Group Price Performance

Shares of CME opened at $205.29 on Wednesday. CME Group has a 12 month low of $190.70 and a 12 month high of $223.80. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.01. The stock has a fifty day moving average price of $198.36 and a 200 day moving average price of $207.02. The company has a market cap of $73.92 billion, a P/E ratio of 23.35, a PEG ratio of 6.27 and a beta of 0.52.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Gold Investment Management Ltd. purchased a new position in shares of CME Group during the fourth quarter valued at $26,000. Northwest Financial Advisors acquired a new stake in CME Group during the 4th quarter worth about $28,000. Salomon & Ludwin LLC acquired a new stake in CME Group during the 1st quarter worth about $28,000. Y.D. More Investments Ltd purchased a new position in CME Group during the 2nd quarter valued at about $36,000. Finally, McClarren Financial Advisors Inc. increased its holdings in shares of CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 78 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at CME Group

In other CME Group news, Director Charles P. Carey sold 3,000 shares of the company’s stock in a transaction dated Thursday, June 13th. The shares were sold at an average price of $195.44, for a total value of $586,320.00. Following the completion of the sale, the director now directly owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other CME Group news, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction that occurred on Thursday, June 13th. The shares were sold at an average price of $195.44, for a total value of $586,320.00. Following the transaction, the director now owns 7,163 shares in the company, valued at $1,399,936.72. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Daniel R. Glickman sold 650 shares of the stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $201.44, for a total value of $130,936.00. Following the sale, the director now owns 14,008 shares of the company’s stock, valued at approximately $2,821,771.52. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 4,650 shares of company stock valued at $928,776. Corporate insiders own 0.30% of the company’s stock.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th will be paid a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.24%. The ex-dividend date of this dividend is Monday, September 9th. CME Group’s dividend payout ratio is presently 52.33%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.